PeptiDream Announces New Peptide Drug Conjugate (“PDC”) Collaboration Agreement with Novartis Life Science
NMPA Accepts New Drug Application for IBI301, a Biosimilar Product Candidate of Rituximab (MabThera/Rituxan) Life Science
Johnson & Johnson Opens JLABS @ Shanghai, a Life Science Incubator with 31 Resident Startups Life Science
China News Weekly 116 – Chinese electric automaker BYD opens first plant in Canada Cannabis, Life Science, Technology
I-Mab Announces Dosing of First Patient in a Phase I Clinical Trial of TJC4, a Potentially Differentiated CD47 Antibody, for the Treatment of Cancers in the United States Life Science
Sinopharm Leads $20 Million Investment in Singapore’s Novena; Plans Joint $150 Million Healthcare Fund Life Science